The observation that the isopropyl moiety is a key structure that escapes recognition by MGMT can potentially be applied to cancer chemotherapy, since recent clinical trials have been undertaken to test DNA repair inhibitors that target PARP, BER, or MGMT in combination with alkylating agents [38]. The gene discussed is PARP1; the disease is cancer.